Clinical Trial Update: Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

View source ↗

Summary

This update covers a prospective non-interventional study of Asciminib for adult patients with chronic myeloid leukemia in chronic phase, as third-line therapy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myeloid Leukemia | Status: ACTIVE_NOT_RECRUITING